NCT00046020已完成4 期
An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term Randomized, Placebo-Controlled Maintenance Treatment Study in Patients Treated Initially With Venlafaxine ER
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 1,096 人开始时间: 2000年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,096
研究概览
简要总结
The purpose of this study is to review the long-term comparative efficacy of venlafaxine ER in achieving and sustaining remission (wellness) in patients with recurrent major depression
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis for recurrent major depression
排除标准
- •The patient has failed on an adequate trial of fluoxetine, venlafaxine or venlafaxine ER during the current episode of major depression or the patient is treatment-resistant
- •Known hypersensitivity to venlafaxine or fluoxetine
- •History or presence of clinically significant hepatic, cardiovascular or renal disease, or other serious medical disease, including history of seizure disorder
研究者
相似试验
已完成
4 期
Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XRAnxiety DisordersNCT00183274University of Pennsylvania268
已完成
不适用
Study Evaluating Venlafaxine Extended Release in Elderly Depressed PatientsDepressive SyndromeAnxietyNCT00247429Wyeth is now a wholly owned subsidiary of Pfizer59
已完成
3 期
Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderPanic DisordersNCT00195598Wyeth is now a wholly owned subsidiary of Pfizer70
尚未招募
2 期
Comparison of the effect of Venlafaxine and Oxybutynin in the Treatment of Hot FlashesBreast Cancer.Malignant neoplasm of breastIRCT20210822052256N1Esfahan University of Medical Sciences64
Unknown
2 期
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive DisorderMajor Depressive DisorderNCT01977378Jiangsu Hansoh Pharmaceutical Co., Ltd.300